Quality of life considerations in psoriasis treatment.
Psoriasis can have a profound impact on a patient, interfering in all aspects of life. Therefore, measuring the impact of disease and the effects of treatment must include both physiologic measurements as well as health-related quality of life tools. Psychosocial evaluation of patients at risk allows for early interventions that will promote positive patient outcomes and compliance with the treatment pathways.
Department of Dermatology, Stanford University Medical Center, Stanford, CA, USA.
Stefan C
SC
Weiss
Kendra G
KG
Bergstrom
Sally A
SA
Weiss
Alexa B
AB
Kimball
D000203:Activities of Daily Living; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001294:Attitude to Health; D001828:Body Image; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006304:Health Status; D006305:Health Status Indicators; D006801:Humans; D024802:Nurse's Role; D009733:Nursing Diagnosis; D011701:PUVA Therapy; D010347:Patient Care Planning; D011565:Psoriasis / Q000188:drug therapy / Q000451:nursing* / Q000523:psychology*; D011788:Quality of Life; D012649:Self Concept; D012934:Social Isolation; D016312:Treatment Refusal
D000893:Anti-Inflammatory Agents; C055085:calcipotriene; D002117:Calcitriol